News Trump pledges 'bidding' to cut drug prices, stocks tumble Donald Trump’s first press conference of the year may have been farcical at times, as he fought off salacious allegations about his links with Russia, but the president-elect's attack on dr
News "I'm going to bring down drug prices" - Trump President-elect takes swipe at pharma after Time "Person of the Year" accolade.
News NHS leader calls for more money ahead of budget GPs and social care need cash to match demand, says NHS Providers.
News How will Trump presidency affect biosimilars in US? Trump makes vague promise to "reform" FDA - but how?
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.